Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

GSK sees strong Japan performance as foundation for new investments

This article was originally published in Scrip

Executive Summary

There were no two ways about it, GlaxoSmithKline had a stellar year in Japan in 2011, driven by new products and surging sales of its human papillomavirus vaccine Cervarix.



Related Companies